Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
Status:
Completed
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, 3-period, placebo-controlled, crossover study to examine the efficacy
and safety of AD182 and AD504 versus placebo in patients with obstructive sleep apnea.